Mangoceuticals MGRX 深 沪
已收盘 11-13 16:00:00 美东时间
0.155
-0.030
-16.22%
华盛通- 最 高0.1876
- 今 开0.1721
- 成交量 96.88万股
- 最 低 0.1495
- 昨 收 0.185
- 总市值 344.48万
- 52周最高 1.38
- 市盈率 静 --
- 换手率 4.36%
- 52周最低 0.1495
- 委 比 -46.31%
- 总股本 2222.44万
- 历史最高 65.55
- 量 比 0.49
- 振 幅 20.59%
- 历史最低 0.1495
- 每 手 1
- 风险率 0.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Mangoceuticals Establishes Series D Preferred Stock Designation
Mangoceuticals, Inc. ( ($MGRX) ) has provided an update. On November 9, 2026, M...
11-14 06:49
Mangoceuticals Partners with T7X to Become the First Nasdaq-Listed Company to Offer Tokenized Preferred Stock on the T7X Platform
Mangoceuticals, Inc. partners with T7X to issue Series D Cumulative Convertible Preferred Stock via tokenization on T7X’s blockchain. The offering, priced at $10 per share, aims to raise up to $10 million with an 8% annual dividend. Tokens represent direct ownership, ensuring compliance through built-in KYC, AML, and transfer restrictions. Conversion to common stock is deferred and tied to a premium price, limiting dilution. Mangoceuticals become...
11-12 12:00
Mangoceuticals completes premium registered direct equity financing
Mangoceuticals, Inc. ( ($MGRX) ) has provided an announcement. On October 8, 20...
10-10 04:35
Mangoceuticals Closes Registered Direct Offering Following $2.5M Strategic Investment Commitment In MangoRx IP Holdings To Support Intellectual Property Commercialization
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization DALLAS, TX, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketin...
10-10 04:03
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Mangoceuticals, Inc. has completed a registered direct offering of approximately $500,000, priced at a 74% premium to its recent share price, providing additional working capital. This follows a $2.5 million strategic investment in its subsidiary, MangoRx IP Holdings, aimed at advancing intellectual property commercialization without diluting the parent company's common stock. The transactions reflect investor confidence in the company's strategy...
10-09 20:01
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: Nike Inc. (NYSE:NKE) reported mixed first-quarter financial results. Nike reported first-quarter revenue of $11.21 billion, missing analyst estimates of $11.33 billion...
10-02 16:16
Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why
Mangoceuticals, Inc. (NASDAQ:MGRX) shares fell 12.24% to $0.42 in after-hours trading Thursday after the company announced its former subsidiary secured a $2.5 million strategic investment. Mangoceuticals develops and sells health and wellness products through a telemedicine platform under the Mango...
10-02 13:22
Mangoceuticals’ MangoRx IP Secures $2.5M Investment From Strategic Investors, Receives Initial $1.75M Tranche
Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company’s Antiviral Intellectual Property Portfolio with No Issuance of MGRX Common Stock DALLAS, TEXAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("Mangoceuticals" or the "Company"), a compan...
10-02 03:52
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche
Mangoceuticals subsidiary MangoRx IP Holdings secures $2.5 million investment from strategic investors, with $1.75 million received as initial tranche. The investment, structured at the subsidiary level, avoids issuing any MGRX common stock, preserving the Company’s capital structure. Funds will support commercialization of antiviral intellectual property, targeting oral care and feed additives markets valued at $34.8 billion and $39.8 billion re...
10-01 19:50
Mangoceuticals Terminates Planned Business Combination with Nuclea
Mangoceuticals, Inc. ( ($MGRX) ) has provided an update. On August 19, 2026, Ma...
08-22 06:02
